At a glance
ClinicalIndex Comparison RecordN/ACompleted· 32 enrolled
Drug / intervention
Verofilcon A contact lensesdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Evaluating the Performance of Precision1 Daily Disposable Contact Lens in a Group of Heavy Digital Device Users
In Brief
A clinical study evaluating Verofilcon A contact lenses for Myopia. Completed, enrolled 32 participants across 1 site.
Detailed Summary
The purpose of this study is to evaluate the performance of Precision1 DD CLs with regard to subjective symptoms (dryness, comfort, vision), lens fit and time to haze in CL wearers who identify themselves as heavy digital devices users (at least 6 hours of digital device use per day).
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMyopia
CountriesCanada
CollaboratorsAlcon Research
Timeline
N/ACompletedFinished
2020202120222023202420252026
Enrollment StartDec 2019
First PostedDec 2019
Primary CompletionSep 2021
TodayJul 2026
First PostedDec 17, 2019
Enrollment StartDec 13, 2019
Primary CompletionSep 27, 2021
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 6.5 years ago
Interventions
Verofilcon A contact lensesdevice
Daily disposable silicone hydrogel contact lenses indicated for the optical correction of refractive ametropia (myopia and hyperopia)